Company Quick10K Filing
Acacia Diversified Holdings
10-Q 2020-06-30 Filed 2020-08-19
10-Q 2020-03-31 Filed 2020-08-07
10-K 2019-12-31 Filed 2020-06-26
10-Q 2019-09-30 Filed 2019-11-12
10-Q 2019-06-30 Filed 2019-08-09
10-Q 2019-03-31 Filed 2019-05-15
S-1 2019-02-14 Public Filing
10-K 2018-12-31 Filed 2019-04-01
10-Q 2018-09-30 Filed 2018-11-05
10-Q 2018-06-30 Filed 2018-08-13
S-1 2018-04-18 Public Filing
10-Q 2018-03-31 Filed 2018-05-07
10-K 2017-12-31 Filed 2018-04-02
10-Q 2017-09-30 Filed 2017-11-13
10-Q 2017-06-30 Filed 2017-08-07
10-Q 2017-03-31 Filed 2017-05-10
10-K 2016-12-31 Filed 2017-03-28
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-15
10-Q 2016-03-31 Filed 2016-05-13
10-K 2015-12-31 Filed 2016-02-12
10-Q 2015-09-30 Filed 2015-11-10
10-Q 2015-06-30 Filed 2015-08-14
10-Q 2015-03-31 Filed 2015-05-20
10-Q 2014-09-30 Filed 2015-05-20
10-Q 2014-06-30 Filed 2015-05-20
10-Q 2014-03-31 Filed 2015-05-20
10-K 2013-12-31 Filed 2015-05-20
10-K 2013-12-31 Filed 2015-05-20
10-Q 2013-09-30 Filed 2013-11-19
10-Q 2013-06-30 Filed 2013-08-13
10-Q 2013-03-31 Filed 2013-05-10
10-K 2012-12-31 Filed 2013-03-28
10-Q 2012-09-30 Filed 2013-02-22
10-Q 2012-06-30 Filed 2013-02-22
10-Q 2012-03-31 Filed 2013-02-22
10-K 2011-12-31 Filed 2013-02-22
10-Q 2010-03-31 Filed 2010-07-23
10-K 2009-12-31 Filed 2010-05-27
8-K 2020-08-06
8-K 2020-05-20
8-K 2020-05-20
8-K 2020-05-15
8-K 2020-05-13
8-K 2020-03-31
8-K 2020-03-26
8-K 2020-02-03
8-K 2019-05-29
8-K 2019-02-14
8-K 2018-07-30

Acacia Diversified Holdings Financials

ACCA Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
20 20 Global (TWGL)
024 Pharma (EEIG)
111 (YI) 0% 1,546,418 322,654 0 0 0 0 -853,740
1 800 Flowers Com (FLWS) 944,324 42% 13.3 6% 664,955 335,559 1,266,390 533,727 36,761 75,090 1,000,932
10x Genomics (TXG) 4,804,979 75% -490.3 -2% 572,815 151,367 61,207 45,727 -9,603 -8,887 4,357,180
12 Retech (RETC) 0 32% -0.1 -1,385% 1,118 20,421 625 199 -15,491 -14,800 966
11 Good Energy (ELVN)
1347 Property Insurance Holdings (PIH) 33,711 0% 0.4 -5% 164,088 108,405 18,194 0 -7,969 -8,017 -2,855
1347 Capital Corp (TFSC)
180 Degree Capital (TURN)
1847 Holdings (EFSH) 25% -2.4 -15% 18,527 23,194 27,219 6,699 -2,862 -1,433 3,396
1895 Bancorp of Wisconsin (BCOW) 46,152,715 12,508.1 -0% 441,187 382,722 0 0 -44 3,689 46,142,359
1st Constitution Bancorp (FCCY) 164,504 0% 4.4 1% 1,342,565 1,204,038 490 0 13,787 32,503 143,748
1st Franklin Financial (FFC) 3,551 -0.6 7% 905,107 644,730 0 0 62,078 80,004 -45,962
24 7 Kid Doc (TVMD)
1st Source (SRCE) 1,200,033 7.9 1% 6,691,070 5,858,028 0 0 70,061 136,342 1,072,548
2050 Motors (ETFM) 0 -0.2 -166,272,400% 0 1,849 0 0 -1,663 -1,654 250
21Vianet Group (VNET) 6,005,116 0% 11,150,717 5,787,533 0 0 0 0 3,344,095
22nd Century (XXII) 301,854 1% -14.1 -36% 61,864 6,554 25,706 304 -22,433 -21,464 301,826
1Life Healthcare (ONEM)

Balance Sheet ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash4220353071894243112159288550318112912313844116135372826495152567975
Accounts Receivable450321280009078992134158012363398952322513611710112
Inventory128240233130858580636058575754544544424027
PP&E1401314847494454232082376766464371366151996510495501590465485475657467428445731441412381
Assets1,3001,1291,0311,0241,22036222767281,3887858919151,0839561,1165232379267367696859281,023920607564547560697872830761
Accounts Payable65051419721720955471171562342531621551619223117706456629527676883102114104
Long-Term Debt61585424241111175253136122235180505002221214181716
Liabilities1,2231,1161,2121,1691,3681351732032749181,1901,2721,3251,3801,301480617621785593956479019631,0921,1951,3741,3641,6501,8371,6521,965
Stockholders' Equity7713-181-145-14922754-135-246470-405-381-410-297-345636462230863558210290281122-43-485-632-827-804-953-965-821-1,204
Income Statement ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue3613400000045103295329365274000226010761481336413492133028116414198
Cost of Revenue514865711517822510672414779957019585052678072169128
Gross Profit310292-555179152139168154-41-38-25363457642-40-3817491-29-31
R&D
SG&A206174924613912581106-101355751452297612223212416864538410283339320344209891207498
Tax000000000000000000000000000000000
Net Income-104-7422-17363-197-118-202-167-66-29412981-174-291-260-305-363-857-695-510-154-460-433-530-560-189-198-510-582
Cash Flow ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating22713-895-117-131-3413-6128188-702-555-238-263-85-392-249-309-113-705-66-120-134-69-74-70
Cash Investing801,23780000-1-55-22,347-15-34-110-250-4-20-5-730-24-24-8-11
Cash Financing-251227-9-41-8-16-3-1559-16-13-4-7720-5018179431155385135-28-8721121589710577